Q4 2023 update: private equity deals in pharmaceutical in Europe
In the European pharmaceutical industry, there were 21 private equity deals announced in Q4 2023, worth a total value of…
All articles by Staff Writer
Staff Writer
-
-
Q4 2023 update: M&A activity in pharmaceutical in the UK
In the British pharmaceutical industry, there were 33 M&A deals announced in Q4 2023, worth a total value of $779.7m,…
-
Q4 2023 update: M&A activity in pharmaceutical in Germany
In the German pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total value of $45m,…
-
How did M&A perform in pharmaceutical in Q4 2023?
In the global pharmaceutical industry, there were 426 M&A deals announced in Q4 2023, worth a total value of $84.2bn,…
-
Q4 2023 update: private equity deals in pharmaceutical in Asia-Pacific
In the Asia-Pacific pharmaceutical industry, there were 10 private equity deals announced in Q4 2023, worth a total value of…
-
How did Private equity deals perform in pharmaceutical in Q4 2023?
In the global pharmaceutical industry, there were 66 private equity deals announced in Q4 2023, worth a total value of…
-
Q4 2023 update: private equity deals in pharmaceutical in China
In the Chinese pharmaceutical industry, there were 2 private equity deals announced in Q4 2023, worth a total value of…
-
Q4 2023 update: M&A activity in pharmaceutical in Middle East and Africa
In the Middle East and Africa pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total…
-
Q4 2023 update: private equity deals in pharmaceutical in India
In the Indian pharmaceutical industry, there were 3 private equity deals announced in Q4 2023, worth a total value of…
-
Q4 2023 update: M&A activity in pharmaceutical in Australia
In the Australian pharmaceutical industry, there were 6 M&A deals announced in Q4 2023, worth a total value of $276.3m,…